BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 34780266)

  • 1. Decreased Methylenetetrahydrofolate Reductase Activity Leads to Increased Sensitivity to
    Yu JF; Xu JT; Yang SS; Gao MN; Si HR; Xiong DY; Gu J; Wu ZL; Zhou J; Deng JY
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0146521. PubMed ID: 34780266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the promoter region of methionine transporter gene
    Zhang Y; Wang S; Chen X; Cui P; Chen J; Zhang W
    mBio; 2024 Feb; 15(2):e0207323. PubMed ID: 38179948
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deletion of
    Yang SS; Hu YB; Wang XD; Gao YR; Li K; Zhang XE; Chen SY; Zhang TY; Gu J; Deng JY
    Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28717039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine Antagonizes
    Howe MD; Kordus SL; Cole MS; Bauman AA; Aldrich CC; Baughn AD; Minato Y
    Front Cell Infect Microbiol; 2018; 8():399. PubMed ID: 30483484
    [No Abstract]   [Full Text] [Related]  

  • 5. Monomeric NADH-Oxidizing Methylenetetrahydrofolate Reductases from Mycobacterium smegmatis Lack Flavin Coenzyme.
    Sah S; Lahry K; Talwar C; Singh S; Varshney U
    J Bacteriol; 2020 May; 202(12):. PubMed ID: 32253341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mycobacterium tuberculosis folate metabolism and the mechanistic basis for para-aminosalicylic acid susceptibility and resistance.
    Minato Y; Thiede JM; Kordus SL; McKlveen EJ; Turman BJ; Baughn AD
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5097-106. PubMed ID: 26033719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mycobacterium tuberculosis Arylamine N-Acetyltransferase Acetylates and Thus Inactivates para-Aminosalicylic Acid.
    Wang X; Yang S; Gu J; Deng J
    Antimicrob Agents Chemother; 2016 Dec; 60(12):7505-7508. PubMed ID: 27671064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-resistance of isoniazid, para-aminosalicylic acid and pasiniazid against isoniazid-resistant Mycobacterium tuberculosis isolates in China.
    Li G; Zhang J; Jiang Y; Zhao LL; Liu H; Li M; Zhao X; Wan K
    J Glob Antimicrob Resist; 2020 Mar; 20():275-281. PubMed ID: 31425771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis.
    Chakraborty S; Gruber T; Barry CE; Boshoff HI; Rhee KY
    Science; 2013 Jan; 339(6115):88-91. PubMed ID: 23118010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetics of para-aminosalicylic acid resistance in clinical isolates and spontaneous mutants of Mycobacterium tuberculosis.
    Mathys V; Wintjens R; Lefevre P; Bertout J; Singhal A; Kiass M; Kurepina N; Wang XM; Mathema B; Baulard A; Kreiswirth BN; Bifani P
    Antimicrob Agents Chemother; 2009 May; 53(5):2100-9. PubMed ID: 19237648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between mutations in a
    Zeng R; He L; Zhang B; Hu Y; Yu J; Yang S; Gu J; Wu Z; Deng J
    Emerg Microbes Infect; 2023 Dec; 12(2):2276339. PubMed ID: 38029724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. dfrA thyA Double Deletion in para-Aminosalicylic Acid-Resistant Mycobacterium tuberculosis Beijing Strains.
    Moradigaravand D; Grandjean L; Martinez E; Li H; Zheng J; Coronel J; Moore D; Török ME; Sintchenko V; Huang H; Javid B; Parkhill J; Peacock SJ; Köser CU
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3864-7. PubMed ID: 27021327
    [No Abstract]   [Full Text] [Related]  

  • 13. Thr202Ala in thyA is a marker for the Latin American Mediterranean lineage of the Mycobacterium tuberculosis complex rather than para-aminosalicylic acid resistance.
    Feuerriegel S; Köser C; Trübe L; Archer J; Rüsch Gerdes S; Richter E; Niemann S
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4794-8. PubMed ID: 20805400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mutations in the thymidylate synthase gene is a major mechanism in the para-aminosalicylic acid resistance of M. tuberculosis].
    Zhang ZD; Zhao YL; Li ZH; Jia HY; Liu YH; Chen X; Liu ZQ; Du BP; Xing AY; Ma Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Sep; 30(9):683-5. PubMed ID: 18070553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Insights into Mycobacterium tuberculosis Rv2671 Protein as a Dihydrofolate Reductase Functional Analogue Contributing to para-Aminosalicylic Acid Resistance.
    Cheng YS; Sacchettini JC
    Biochemistry; 2016 Feb; 55(7):1107-19. PubMed ID: 26848874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding pocket alterations in dihydrofolate synthase confer resistance to para-aminosalicylic acid in clinical isolates of Mycobacterium tuberculosis.
    Zhao F; Wang XD; Erber LN; Luo M; Guo AZ; Yang SS; Gu J; Turman BJ; Gao YR; Li DF; Cui ZQ; Zhang ZP; Bi LJ; Baughn AD; Zhang XE; Deng JY
    Antimicrob Agents Chemother; 2014; 58(3):1479-87. PubMed ID: 24366731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multi-omics comparisons of p-aminosalicylic acid (PAS) resistance in folC mutated and un-mutated Mycobacterium tuberculosis strains.
    Wei W; Yan H; Zhao J; Li H; Li Z; Guo H; Wang X; Zhou Y; Zhang X; Zeng J; Chen T; Zhou L
    Emerg Microbes Infect; 2019; 8(1):248-261. PubMed ID: 30866779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis.
    Zheng J; Rubin EJ; Bifani P; Mathys V; Lim V; Au M; Jang J; Nam J; Dick T; Walker JR; Pethe K; Camacho LR
    J Biol Chem; 2013 Aug; 288(32):23447-56. PubMed ID: 23779105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of a new class of isonicotinoylhydrazones used alone and in combination with isoniazid, rifampicin, ethambutol, para-aminosalicylic acid and clofazimine against Mycobacterium tuberculosis.
    De Logu A; Onnis V; Saddi B; Congiu C; Schivo ML; Cocco MT
    J Antimicrob Chemother; 2002 Feb; 49(2):275-82. PubMed ID: 11815568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drugging the Folate Pathway in Mycobacterium tuberculosis: The Role of Multi-targeting Agents.
    Hajian B; Scocchera E; Shoen C; Krucinska J; Viswanathan K; G-Dayanandan N; Erlandsen H; Estrada A; Mikušová K; Korduláková J; Cynamon M; Wright D
    Cell Chem Biol; 2019 Jun; 26(6):781-791.e6. PubMed ID: 30930162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.